» Articles » PMID: 21483793

A Potential Role for Shed Soluble Major Histocompatibility Class I Molecules As Modulators of Neurite Outgrowth

Overview
Journal PLoS One
Date 2011 Apr 13
PMID 21483793
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The neurobiological activities of classical major histocompatibility class I (MHCI) molecules are just beginning to be explored. To further examine MHCI's actions during the formation of neuronal connections, we cultured embryonic mouse retina explants a short distance from wildtype thalamic explants, or thalami from transgenic mice (termed "NSE-Db") whose neurons express higher levels of MHCI. While retina neurites extended to form connections with wildtype thalami, we were surprised to find that retina neurite outgrowth was very stunted in regions proximal to NSE-Db thalamic explants, suggesting that a diffusible factor from these thalami inhibited retina neurite outgrowth. It has been long known that MHCI-expressing cells release soluble forms of MHCI (sMHCI) due to the shedding of intact MHCI molecules, as well as the alternative exon splicing of its heavy chain or the action proteases which cleave off it's transmembrane anchor. We show that the diffusible inhibitory factor from the NSE-Db thalami is sMHCI. We also show that COS cells programmed to express murine MHCI release sMHCI that inhibits neurite outgrowth from nearby neurons in vitro. The neuroinhibitory effect of sMHCI could be blocked by lowering cAMP levels, suggesting that the neuronal MHCI receptor's signaling mechanism involves a cyclic nucleotide-dependent pathway. Our results suggest that MHCI may not only have neurobiological activity in its membrane-bound form, it may also influence local neurons as a soluble molecule. We discuss the involvement of complement proteins in generating sMHCI and new theoretical models of MHCI's biological activities in the nervous system.

Citing Articles

CD3ζ-Mediated Signaling Protects Retinal Ganglion Cells in Glutamate Excitotoxicity of the Retina.

Du R, Wang P, Tian N Cells. 2024; 13(12.

PMID: 38920637 PMC: 11201742. DOI: 10.3390/cells13121006.


An innate immune response to adeno-associated virus genomes decreases cortical dendritic complexity and disrupts synaptic transmission.

Suriano C, Kumar N, Verpeut J, Ma J, Jung C, Dunn C Mol Ther. 2024; 32(6):1721-1738.

PMID: 38566414 PMC: 11184335. DOI: 10.1016/j.ymthe.2024.03.036.


Open MHC Class I Conformers: A Look through the Looking Glass.

Arosa F, Esgalhado A, Reste-Ferreira D, Cardoso E Int J Mol Sci. 2021; 22(18).

PMID: 34575902 PMC: 8470049. DOI: 10.3390/ijms22189738.


CD45RA, CD8β, and IFNγ Are Potential Immune Biomarkers of Human Cognitive Function.

Esgalhado A, Reste-Ferreira D, Albino S, Sousa A, Amaral A, Martinho A Front Immunol. 2020; 11:592656.

PMID: 33324408 PMC: 7723833. DOI: 10.3389/fimmu.2020.592656.


MiR34a Regulates Neuronal MHC Class I Molecules and Promotes Primary Hippocampal Neuron Dendritic Growth and Branching.

Hu Y, Pei W, Hu Y, Li P, Sun C, du J Front Cell Neurosci. 2020; 14:573208.

PMID: 33192317 PMC: 7655649. DOI: 10.3389/fncel.2020.573208.


References
1.
Stefansson H, Ophoff R, Steinberg S, Andreassen O, Cichon S, Rujescu D . Common variants conferring risk of schizophrenia. Nature. 2009; 460(7256):744-7. PMC: 3077530. DOI: 10.1038/nature08186. View

2.
Neumann H, Schmidt H, Cavalie A, Jenne D, Wekerle H . Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha. J Exp Med. 1997; 185(2):305-16. PMC: 2196130. DOI: 10.1084/jem.185.2.305. View

3.
Torres A, Sweeten T, Cutler A, Bedke B, Fillmore M, Stubbs E . The association and linkage of the HLA-A2 class I allele with autism. Hum Immunol. 2006; 67(4-5):346-51. DOI: 10.1016/j.humimm.2006.01.001. View

4.
Chisholm A, Tessier-Lavigne M . Conservation and divergence of axon guidance mechanisms. Curr Opin Neurobiol. 1999; 9(5):603-15. DOI: 10.1016/S0959-4388(99)00021-5. View

5.
Aulitzky W, Grosse-Wilde H, Westhoff U, Tilg H, Aulitzky W, Gastl G . Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma). Clin Exp Immunol. 1991; 86(2):236-9. PMC: 1554123. DOI: 10.1111/j.1365-2249.1991.tb05802.x. View